Integumen upbeat on promising cannabis skincare test results
Deepverge Plc
0.15p
17:30 19/12/23
Integumen announced positive results from further tests in formulations on Monday, all of which contained low-concentrations of hemp-derived cannabinoid (CBD) oils.
FTSE AIM All-Share
753.12
16:50 25/04/24
Personal Goods
15,870.16
17:09 25/04/24
The AIM-traded firm said the formulations increased production of pro-collagen, and indicated a reduction of inflammation on ‘Labskin’, leading to a soothing effect on irritated and sore skin.
It explained that pro-collagen had been shown to improve the “youthfulness” of skin appearance, and was a precursor of collagen - the protein that adds strength and support to body tissue.
The amount of pro-collagen production could be directly measured, as no additional collagen was added to the Labskin model.
Inflammation, meanwhile, could be caused by a variety of reasons ranging from bacterial infection to irritation from harsh skin products, Integumen explained.
It said Labskin was capable of releasing chemical markers that indicated inflammation damage occurring on the skin test model.
The trial data showed that formulations containing hemp-derived CBD oil, in low concentrations, reduced the release of those inflammation markers, indicating a soothing effect on sore skin.
Ingegume’s updates on 7 January and 20 February noted that Cellulac, which is 9.35% owned by Integumen, had developed a low-cost hemp-derived CBD oil extraction process and was collaborating with Labskin to provide a formulation for the ‘STOER For Men’ range of cosmetics.
“Scientific evidence to back up anti-ageing or problematic skin treatments is far superior to anecdotal percentages of product testers,” said Integumen chief executive officer Gerard Brandon.
“With no animal testing allowed, consumers still have a right to know what the real impact and effect of products have on their skin, before they use it.”
Further tests and product approvals were still required before consideration of launching an extension to the range of STOER For Men skin care products, Brandon explained.
“Labskin is now offering the same test services to clients adding CBD to their skin-care and cosmetic range of products.”